 |
|
|
| |
Effect of Renal Function on the Pharmacokinetics of Ombitasvir/Paritaprevir/Ritonavir, Dasabuvir and Ribavirin in Over 2000 Subjects with HCV GT1 Infection
|
| |
| |
Reported by Jules Levin
AASLD 2015 Nov 13-17 San Francisco
A.R. Polepally1, P. S. Badri1, D. Eckert2, S. Mensing2, R. M. Menon1 1AbbVie Inc., Clinical Pharmacology and Pharmacometrics, North Chicago, IL, USA 2AbbVie Deutschland GmbH & Co.KG, Clinical Pharmacology and Pharmacometrics, Ludwigshafen, Germany
|
| |
|
|
|
|
|
